Cargando…

FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription

OBJECTIVE: The aim of the present study was to investigate the effect of forkhead box M1 (FOXM1) to paclitaxel resistance in cervical cancer cells, to determine the underlying mechanism, and to identify novel targets for the treatment of paclitaxel-resistant cervical cancer. METHODS: Paclitaxel-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Youxiang, Dong, Zhanfei, Zhong, Wei, Yin, Linglong, Li, Xiong, Kuerban, Gulina, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820921/
https://www.ncbi.nlm.nih.gov/pubmed/35141332
http://dx.doi.org/10.1155/2022/3032590
_version_ 1784646310218956800
author Hou, Youxiang
Dong, Zhanfei
Zhong, Wei
Yin, Linglong
Li, Xiong
Kuerban, Gulina
Huang, He
author_facet Hou, Youxiang
Dong, Zhanfei
Zhong, Wei
Yin, Linglong
Li, Xiong
Kuerban, Gulina
Huang, He
author_sort Hou, Youxiang
collection PubMed
description OBJECTIVE: The aim of the present study was to investigate the effect of forkhead box M1 (FOXM1) to paclitaxel resistance in cervical cancer cells, to determine the underlying mechanism, and to identify novel targets for the treatment of paclitaxel-resistant cervical cancer. METHODS: Paclitaxel-resistant Caski cells (Caski/Taxol cells) were established by intermittently exposing the Caski cells to gradually increasing concentrations of paclitaxel. The association between FOXM1, ATP-binding cassette subfamily C member 5 (ABCC5), and cervical cancer cell drug resistance was assessed by overexpressing or knocking down the expression of FOXM1 in Caski or Caski/Taxol cells. The protein and mRNA expression levels, the ratio of cellular apoptosis, and cell migration as well as intracellular drug concentrations were measured in cells following the different treatments. RESULTS: After the successful establishment of resistant Caski/Taxol cells, cell cycle distribution analysis showed that a significantly larger percentage of Caski/Taxol cells was in the G0/G1 stage compared with the Caski cells (P < 0.01), whereas a significantly larger percentage of Caski cells was in the S and G2/M stage compared with the Caski/Taxol cells following treatment with paclitaxel (P < 0.01). Both the protein and mRNA expression levels of FOXM1 and ABCC5 transporters were significantly higher in the paclitaxel-resistant Caski/Taxol cells compared with Caski cells (P < 0.05). Knockdown of FOXM1 significantly lowered the protein expression levels of FOXM1 and ABCC5. Intracellular paclitaxel concentrations were significantly higher amongst the Caski/Taxol cells following the knockdown of FOXM1 by shRNA or Siomycin A (P < 0.05). CONCLUSION: FOXM1 promotes drug resistance in cervical cancer cells by regulating ABCC5 gene transcription. The knockdown of FOXM1 with shRNA or Siomycin A promotes paclitaxel-induced cell death by regulating ABCC5 gene transcription.
format Online
Article
Text
id pubmed-8820921
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88209212022-02-08 FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription Hou, Youxiang Dong, Zhanfei Zhong, Wei Yin, Linglong Li, Xiong Kuerban, Gulina Huang, He Biomed Res Int Research Article OBJECTIVE: The aim of the present study was to investigate the effect of forkhead box M1 (FOXM1) to paclitaxel resistance in cervical cancer cells, to determine the underlying mechanism, and to identify novel targets for the treatment of paclitaxel-resistant cervical cancer. METHODS: Paclitaxel-resistant Caski cells (Caski/Taxol cells) were established by intermittently exposing the Caski cells to gradually increasing concentrations of paclitaxel. The association between FOXM1, ATP-binding cassette subfamily C member 5 (ABCC5), and cervical cancer cell drug resistance was assessed by overexpressing or knocking down the expression of FOXM1 in Caski or Caski/Taxol cells. The protein and mRNA expression levels, the ratio of cellular apoptosis, and cell migration as well as intracellular drug concentrations were measured in cells following the different treatments. RESULTS: After the successful establishment of resistant Caski/Taxol cells, cell cycle distribution analysis showed that a significantly larger percentage of Caski/Taxol cells was in the G0/G1 stage compared with the Caski cells (P < 0.01), whereas a significantly larger percentage of Caski cells was in the S and G2/M stage compared with the Caski/Taxol cells following treatment with paclitaxel (P < 0.01). Both the protein and mRNA expression levels of FOXM1 and ABCC5 transporters were significantly higher in the paclitaxel-resistant Caski/Taxol cells compared with Caski cells (P < 0.05). Knockdown of FOXM1 significantly lowered the protein expression levels of FOXM1 and ABCC5. Intracellular paclitaxel concentrations were significantly higher amongst the Caski/Taxol cells following the knockdown of FOXM1 by shRNA or Siomycin A (P < 0.05). CONCLUSION: FOXM1 promotes drug resistance in cervical cancer cells by regulating ABCC5 gene transcription. The knockdown of FOXM1 with shRNA or Siomycin A promotes paclitaxel-induced cell death by regulating ABCC5 gene transcription. Hindawi 2022-01-31 /pmc/articles/PMC8820921/ /pubmed/35141332 http://dx.doi.org/10.1155/2022/3032590 Text en Copyright © 2022 Youxiang Hou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hou, Youxiang
Dong, Zhanfei
Zhong, Wei
Yin, Linglong
Li, Xiong
Kuerban, Gulina
Huang, He
FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title_full FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title_fullStr FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title_full_unstemmed FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title_short FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription
title_sort foxm1 promotes drug resistance in cervical cancer cells by regulating abcc5 gene transcription
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820921/
https://www.ncbi.nlm.nih.gov/pubmed/35141332
http://dx.doi.org/10.1155/2022/3032590
work_keys_str_mv AT houyouxiang foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT dongzhanfei foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT zhongwei foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT yinlinglong foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT lixiong foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT kuerbangulina foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription
AT huanghe foxm1promotesdrugresistanceincervicalcancercellsbyregulatingabcc5genetranscription